Skip to main content
BrainCited
Figure 4

Description

A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery.

More Figures from This Paper

Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.

Figure 2

Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.

diagram
Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage.

Figure 3

Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage.

diagram
A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies.

Figure 5

A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies.

diagram

Figure 4

Diagram
778 × 544px · 80.0 KB

Source Paper

Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.

Molecules (Basel, Switzerland) (2024)

PMID: 39274904

DOI: 10.3390/molecules29174056

Cite This Figure

![Figure 4: A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery.](https://pdfs.citedhealth.com/figures/39274904/186.png)

> Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." *Molecules (Basel, Switzerland)*, 2024. PMID: [39274904](https://pubmed.ncbi.nlm.nih.gov/39274904/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39274904/186.png" alt="A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery." />
  <figcaption>Figure 4. A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery.<br>  Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." <em>Molecules (Basel, Switzerland)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39274904/">39274904</a></figcaption>
</figure>

Related Evidence

B
Curcumin for Age-Related Cognitive Decline

Grade B · 10 studies

 B
Curcumin for Oxidative Stress & Neuroinflammation

Grade B · 15 studies

 C
Curcumin for Memory Loss

Grade C · 8 studies